Author:
Li Xiaolin,Li Rutian,Qian Xiaoping,Ding Yitao,Tu Yunxia,Guo Rui,Hu Yong,Jiang Xiqun,Guo Wanhua,Liu Baorui
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference37 articles.
1. SBU-group. Swedish Council of Technology Assessment in Health Care, a systematic overview of chemotherapy effects in ovarian cancer;Hogberg;Acta Oncol.,2001
2. Surgical quality in trials of adjuvant cancer therapy;Hundahl;J. Surg. Oncol.,2002
3. Cisplatin nephrotoxicity: a review;Yao;Am. J. Med. Sci.,2007
4. Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles;Xu;Biomacromolecules,2006
5. Antitumor activity of 13,14-dihydro-15-deoxy-D7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian cancer cells resistant to cisplatin in vivo;Sasaki;Cancer Res.,1999
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献